Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of acitretin 25 mg capsules in healthy Thai male volunteers under fed conditions
TCTR20240715010Phase 1Completed
- Sponsor
- Unison Laboratories
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of acitretin (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax at 72 hours and truncated AUC0-72 at 72 hours. Started Jun 2025; status: completed.
02
Drugs
acitretin
Beyond the preview
Go deeper on TCTR20240715010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240715010.